Extreme Movers: DeepSeek's picks for 2026-10-22
DeepSeek picked SPOT, BHVN, LRCX, ATI, TER for a 1-day horizon. Average directional return: +1.33%. Directions called correctly: 80%.
| Experiment | Extreme Movers |
|---|---|
| Model | DeepSeek |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-22 |
| Measured to | 2026-10-23 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | +1.33% |
| Directions called correctly | 80% |
| Benchmark return | -0.28% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | SPOT | up | +2.10% | +2.10% | 65% | +2.38% | Yes |
| 2 | BHVN | down | -5.17% | +5.17% | 60% | +5.45% | Yes |
| 3 | LRCX | down | -0.64% | +0.64% | 58% | +0.92% | Yes |
| 4 | ATI | up | -1.83% | -1.83% | 55% | -1.55% | No |
| 5 | TER | down | -0.59% | +0.59% | 52% | +0.88% | Yes |
The model's market view
US equities are risk-off intraday, with semiconductor and technology hardware names leading losses while select earnings winners outperform. I favor earnings-driven continuation in Spotify and Lam Research's negative guidance reaction, a profit-taking fade in Biohaven's binary biotech spike, and mean-reversion bounces in ATI and Teradyne where selling looks macro- or sector-driven rather than company-specific.
Why each pick
SPOT
Spotify is one of Thursday's largest gainers after Q3 results showed paying subscribers rising to 306 million and improving margin trends. The catalyst is substantive earnings and subscriber growth, not a speculative headline, and post-earnings drift favors continuation. Latest available intraday quote is $570.40 at 12:22 p.m. ET, about 58 minutes before the prediction timestamp, or +8.58% versus the prior close; the cited Benzinga article earlier showed $573.22 and +9.2%. Market cap and 20-day dollar volume are comfortably above the floors; dollar volume is approximated from average share volume and the intraday price. Main risk is a broad tech selloff overwhelming the earnings catalyst.
BHVN
Biohaven is the top gainer after the FDA accepted the resubmitted NDA for Vyglxia in spinocerebellar ataxia. The regulatory catalyst is substantive, but the 27% intraday spike is a binary biotech re-rating and is vulnerable to profit-taking and dilution/execution concerns. I therefore fade the move as a reversal. Latest available midday quote is $14.94, about +27.15% versus the prior close; the cited Benzinga article earlier reported $15.36 and +30.5%. Market cap is about $2.26 billion and 20-day dollar volume is around $48 million, so both floors are met. Main risk is continued momentum on the FDA acceptance.
LRCX
Lam Research is a top loser after current-quarter guidance only met expectations and management flagged supply constraints and a sharp drop in China customer revenue, reviving AI-spending fears. The catalyst is substantive guidance deterioration, so I expect continuation lower rather than an immediate bounce. Latest quote is $237.12 at 16:36 UTC, about 44 minutes before the prediction timestamp, or -9.08% versus the prior close. Market cap is roughly $326 billion and 20-day dollar volume is over $2 billion, well above the floors. Main risk is a violent oversold rebound after a record revenue quarter.
ATI
ATI is the largest loser in the cited list, down almost 10% without a company-specific announcement. The move tracks a broad risk-off tone in aerospace, defense and specialty-materials names, so the catalyst is speculative and macro-driven rather than a fundamental earnings miss. A one-day 10% drop on sector rotation is a plausible mean-reversion setup, hence reversal higher. Latest available list quote is $162.64 at 13:45 UTC, about 3.5 hours stale, or -9.99% versus the prior close. Market cap is about $24.6 billion and 20-day dollar volume is roughly $264 million, so the screening floors are met. Main risk is continued sector de-risking.
TER
Teradyne is a top-ten loser caught in the Nasdaq technology selloff and a broader valuation reset in semiconductor equipment, with no company-specific negative headline identified. The catalyst is speculative and sector-driven, and momentum into the close favors continuation lower. Latest quote is $317.89 at 14:12 UTC, about 3 hours stale, or -7.99% versus the prior close. Market cap is roughly $54 billion and 20-day dollar volume is about $900 million, so all floors are satisfied. Main risk is a sharp tech bounce that lifts the whole complex.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Claude Opus 5.5 | SMCI, MSTR, T, CRL, NFLX | -2.33% | 20% |
| Grok 4.5 | BHVN, TTMI, CRS, POOL, SPOT | -1.34% | 60% |
| Gemini 3 Pro | BHVN, POOL, TTMI, CRS, KALU | -5.83% | 0% |
| Muse Spark 1.1 | BHVN, TTMI, MRNA, ALLE, POOL | +0.12% | 60% |
| GPT-6 | BE, SMCI, NFLX, CRL, DXCM | +2.45% | 60% |
Written up on ForecastNest Insights: Extreme Movers: DeepSeek's picks for 2026-10-22.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.